Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of inhaled PT005 compared to
placebo and Formoterol Fumarate (Foradil Aerolizer) in patients with moderate to severe
chronic obstructive pulmonary disease (COPD).